Related Experiment Video

Updated: Jun 19, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Pathogen recognition receptors, cancer and inflammation in the gut

Masayuki Fukata1, Maria T Abreu

  • 1Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Locator Code D-149, 1011 NW 15th St, Miami, FL 33136, USA. mfukata@med.miami.edu

Current Opinion in Pharmacology
|October 16, 2009
PubMed

Insights

Pathogen recognition receptors (PRRs) are crucial for host defense and intestinal repair. Abnormal PRR signaling links to gastrointestinal disorders, showing a dual role in promoting tumors while also initiating anti-tumor immunity.

Area of Science:

  • Immunology
  • Gastroenterology
  • Oncology

Background:

  • Pathogen recognition receptors (PRRs) are key to immediate host defense against infection and tissue damage.
  • Intestinal PRR signaling is involved in mucosal repair processes following damage.
  • Aberrant PRR signaling is increasingly linked to inflammatory and neoplastic intestinal disorders.

Purpose of the Study:

  • To explore the dual role of PRRs in intestinal diseases, specifically their involvement in both tumorigenesis and antitumor immunity.
  • To understand how PRR signaling influences tumor cell proliferation, immune evasion, and apoptosis.
  • To highlight the potential of targeting PRR signaling for novel gastrointestinal disease therapies.

Main Methods:

  • Review of recent advances in understanding PRR signaling in the context of intestinal disorders.
  • Analysis of molecular mechanisms, including NF-kappaB and TLR signaling pathways.
  • Examination of the role of endogenous PRR ligands in epithelial cells during damage and neoplastic transformation.

Main Results:

  • PRRs exhibit a dual role, potentially inducing tumor cell proliferation via survival pathways (e.g., NF-kappaB) while also activating dendritic cells for antitumor immunity.
  • TLR signaling in tumor cells can lead to immune evasion and metastatic growth or, conversely, tumor cell apoptosis, depending on specific ligands.
  • Epithelial cells release endogenous PRR ligands upon damage or neoplastic transformation.

Conclusions:

  • PRR signaling plays a complex role in gastrointestinal diseases, influencing both cancer development and the host's immune response against tumors.
  • Targeted manipulation of PRR signaling pathways presents a promising avenue for developing new therapeutic strategies for various gastrointestinal conditions.

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...